image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 76.83
-4.96 %
$ 5.34 B
Market Cap
12.76
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 38.65% 1063.86% 2813.72%
Annual Report FY 10-K 2022-12-31 119.91% 139.38% 82.34%
Annual Report FY 10-K 2021-12-31 25.28% -429.05% -1712.48%
Annual Report FY 10-K 2020-12-31 -2.28% -42.55% -13.09%
Annual Report FY 10-K 2019-12-31 1.15% -21.84% -50.28%
Annual Report FY 10-K 2018-12-31 3.62% -67.16% 24.37%
Annual Report FY 10-K 2017-12-31 9.78% 361.05% -8.37%
Annual Report FY 10-K 2016-12-31 2.86% 281.49% 33.05%
Annual Report FY 10-K 2015-12-31 -2.70% -314.10% 7.90%
Annual Report FY 10-K 2014-12-31 6.32% 94.21% 308.65%
Annual Report FY 10-K 2013-12-31 -1.54% -46.56% -2418.80%
Annual Report FY 10-K 2012-12-31 -19.14% 69.40% 95.66%
Annual Report FY 10-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 18.37% -0.65% 19.03%
Quarterly Report Q2 8-K 2024-06-30 22.50% -34.06% -17.33%
Quarterly Report Q1 8-K 2024-03-31 23.00% 4769.26% 1174.28%
Quarterly Report Q4 8-K 2023-12-31 34.52% 186.74% 180.08%
Quarterly Report Q3 8-K 2023-09-30 33.71% 115.50% 31.04%
Quarterly Report Q2 8-K 2023-06-30 43.79% 118.61% 96.41%
Quarterly Report Q1 8-K 2023-03-31 44.00% -6.53% -15.86%
Quarterly Report Q4 8-K 2022-12-31 103.12% -196.37% -385.81%
Quarterly Report Q3 8-K 2022-09-30 134.43% 556.44% 698.43%
Quarterly Report Q2 8-K 2022-06-30 121.37% 261.53% 336.00%
Quarterly Report Q1 8-K 2022-03-31 125.79% 376.93% 277.19%
Quarterly Report Q4 8-K 2021-12-31 37.61% -1078.63% -6592.80%
Quarterly Report Q3 8-K 2021-09-30 15.28% -110.07% -172.91%
Quarterly Report Q2 8-K 2021-06-30 53.10% -280.16% -382.98%
Quarterly Report Q1 8-K 2021-03-31 1.99% 169.94% 119.26%
Quarterly Report Q4 8-K 2020-12-31 5.38% -32.65% -4.25%
Quarterly Report Q3 8-K 2020-09-30 3.23% -131.51% -61.64%
Quarterly Report Q2 8-K 2020-06-30 -22.98% -109.36% -38.14%
Quarterly Report Q1 8-K 2020-03-31 4.85% -66.46% -55.93%
Quarterly Report Q4 8-K 2019-12-31 3.56% -21.39% -26.59%
Quarterly Report Q3 8-K 2019-09-30 -3.51% -47.61% -48.33%
Quarterly Report Q2 8-K 2019-06-30 0.15% -34.20% -8.72%
Quarterly Report Q1 8-K 2019-03-31 4.70% 21.17% 6.82%
Quarterly Report Q4 8-K 2018-12-31 6.19% -86.31% 84.02%
Quarterly Report Q3 8-K 2018-09-30 11.21% 8.71% 28.54%
Quarterly Report Q2 8-K 2018-06-30 -3.67% -28.32% -11.01%
Quarterly Report Q1 8-K 2018-03-31 1.56% 98.43% 26.91%
Quarterly Report Q4 8-K 2017-12-31 9.27% 1894.78% -24.17%
Quarterly Report Q3 8-K 2017-09-30 9.41% 102.04% 1.80%
Quarterly Report Q2 8-K 2017-06-30 13.94% 84.97% 26.22%
Quarterly Report Q1 8-K 2017-03-31 6.39% -59.91% -32.51%
Quarterly Report Q4 8-K 2016-12-31 4.42% 24.34% -1.99%
Quarterly Report Q3 8-K 2016-09-30 -1.43% -21.65% -6.06%
Quarterly Report Q2 8-K 2016-06-30 6.35% 130.09% 164.73%
Quarterly Report Q1 8-K 2016-03-31 2.21% 2652.80% 55.33%
Quarterly Report Q4 8-K 2015-12-31 -7.49% 1625.11% 5.64%
Quarterly Report Q3 8-K 2015-09-30 -2.06% 721.22% 45.41%
Quarterly Report Q2 8-K 2015-06-30 -3.04% -1392.85% -46.33%
Quarterly Report Q1 8-K 2015-03-31 2.03% 129.18% 34.03%
Quarterly Report Q4 8-K 2014-12-31 7.40% 101.85% 979.09%
Quarterly Report Q3 8-K 2014-09-30 7.53% 94.24% 301.86%
Quarterly Report Q2 8-K 2014-06-30 7.10% 88.62% 365.92%
Quarterly Report Q1 8-K 2014-03-31 3.26% 93.51% 191.91%
Quarterly Report Q4 8-K 2013-12-31 -0.80% -28.82% -119.11%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%